Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0000947871-20-000146

Options or other derivatives

  • Director sold 1,292,408 shares at $0.20 ($258,482)

From the SEC's structured data for this filing

Trades in this filing

OrbiMed Israel GP Ltd. · Director

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-01-14 Sale : show line 1 in the form Warrants to Purchase Common Stock +646,204 $0.20 $129,241 I
2020-01-14 Sale : show line 2 in the form Warrants to Purchase Common Stock +646,204 $0.20 $129,241 I
Loading xslF345X03/ownership.xml…